Risperidone-induced hyperprolactinemia in a premenopausal woman: a case report
No Thumbnail Available
Date
2018
Journal Title
Journal ISSN
Volume Title
Publisher
University of Lagos Medical Society, University of Lagos
Abstract
A common side effect of antipsychotic medications used to treat psychotic patients is hyperprolactinemia. Its occurrence leads to dysfunction of the reproductive, endocrine and metabolic systems. This side effect which may be symptomatic or asymptomatic, is commonly under reported and under treated and may result in poor compliance. We present the case of a 35year old patient
treated for psychotic depression with atypical antipsychotics, Risperidone and Amitrypiline, who presented with galactorrhea and amenorrhea which led her to stop her medications and consequently, a resurgence of the primary illness. Hormonal assay showed elevated Prolactin level which reduced significantly with institution of dopamine agonist Bromocriptine and a switch in medication
to Aripripazole. These are examples of treatment strategies suggested in literatures reviewed. We recommended that clinicians pay more attention to hyperproclactenimia as an important side effect seen in patients taking antipsychotics which may reduce compliance.
Description
Keywords
Hyperprolactinemia, Antipsychotic, Risperidone
Citation
BUHARI OIN, Ogunmodede AJ, Adegunloye OA, Biliaminu SA, Wahab OA. (2018). Risperidone-induced hyperprolactinemia in a premenopausal woman: a case report. Nigerian Quarterly Journal of Hospital Medicine, 28(3): 174-177